These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 427002)

  • 1. Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia.
    Jennings GL; Bobik A; Fagan ET; Korner PI
    Br J Clin Pharmacol; 1979 Mar; 7(3):245-56. PubMed ID: 427002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of propranolol and pindolol on plasma ANP levels in humans at rest and during exercise.
    Bouissou P; Galen FX; Richalet JP; Lartigue M; Devaux F; Dubray C; Atlan G
    Am J Physiol; 1989 Aug; 257(2 Pt 2):R259-64. PubMed ID: 2527473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the cardiovascular effects of pindolol in DOCA/saline hypertensive rats.
    Buckingham RE; Hamilton TC; Robson D
    Br J Pharmacol; 1977 Jul; 60(3):461-9. PubMed ID: 19118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiments with pindolol (Visken) in healthy volunteers.
    Aellig WH
    Med J Aust; 1977 Sep; 2(SP2):8-11. PubMed ID: 927284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Adrenoceptor blocking effects and pharmacokinetics of pindolol. A study in hypertensive Africans.
    Salako LA; Falase AO; Ragon A; Adio RA
    Eur J Clin Pharmacol; 1979 Jun; 15(5):299-304. PubMed ID: 37094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacodynamics and plasma levels of beta-adrenoceptor blocking drugs.
    Gugler R; Krist R; Raczinski H; Höffgen K; Bodem G
    Br J Clin Pharmacol; 1980 Oct; 10(4):337-43. PubMed ID: 6108780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pindolol on exercise-induced cardiac acceleration in relation to plasma levels in man.
    Gugler R; Höbel W; Bodem G; Dengler HJ
    Clin Pharmacol Ther; 1975 Feb; 17(2):127-33. PubMed ID: 1122674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.
    Aellig WH
    Br J Clin Pharmacol; 1976 Apr; 3(2):251-7. PubMed ID: 973959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
    Aellig WH
    Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the effect of pindolol and propranolol on heart rate after acute and chronic administration.
    Finch MB; O'Connor PC; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1983 Apr; 15(4):431-4. PubMed ID: 6849778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet.
    Aellig WH; Narjes HH; Nüesch E; Oertle RJ; Devos JE; Pacha W
    Eur J Clin Pharmacol; 1981; 20(3):179-83. PubMed ID: 7286035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic heart rate on exercise and the measurement of beta-adrenoceptor blockade.
    Carruthers SG; Shanks RG; McDevitt DG
    Br J Clin Pharmacol; 1976 Dec; 3(6):991-9. PubMed ID: 22216520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity and duration of action of pindolol and alprenolol compared in healthy volunteers.
    Aellig WH
    Eur J Clin Pharmacol; 1978 Dec; 14(5):305-8. PubMed ID: 729623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of pindolol on tachycardia and certain metabolic variations dependent of muscular exertion].
    Cession-Fossion A; Juchmès J; Lecomte J
    Arch Int Physiol Biochim; 1979 Feb; 87(1):95-104. PubMed ID: 92294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
    Tomlinson B; Cronin CJ; Graham BR; Prichard BN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the duration of action of pindolol and slow release oxprenolol in healthy volunteers.
    Aellig WH
    Eur J Clin Pharmacol; 1978 Nov; 14(3):167-9. PubMed ID: 729611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of propranolol and pindolol on plasma lignocaine clearance in man.
    Svendsen TL; Tangø M; Waldorff S; Steiness E; Trap-Jensen J
    Br J Clin Pharmacol; 1982; 13(Suppl 2):223S-226S. PubMed ID: 7104144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T; Mitomi A; Tatebe S; Imai S
    Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
    Himori N; Ishimori T; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.